Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic

Gregory Dwyer, MPH; Adebola Popoola, JD, MPH, MBS; Naomi Seiler, JD; Nicole Therrien, PharmD, MPH; Aaron Karacuschansky, MPH; Erika Fulmer, MHA; Katie Horton, JD, RN, MPH


Prev Chronic Dis. 2022;19(3):e10 

In This Article

Abstract and Introduction


Health system disruption caused by the COVID-19 pandemic prompted public health professionals to reevaluate potential barriers and opportunities to community pharmacist provision of chronic disease management services and to identify opportunities for maximizing community pharmacists' impact. Researchers conducted semistructured interviews with representatives from chronic disease prevention and pharmacy practice and policy organizations to identify key themes across multiple interviews and novel responses of interest. Interviewees described a lack of payment models to support pharmacist-provided chronic disease management services but noted opportunities for community pharmacists to demonstrate their value in offering services they are uniquely positioned to provide and to implement better workflow solutions. Successfully demonstrating pharmacists' value and making the case for reimbursement from payors, as well as optimizing pharmacy workflow, are critical to maximizing pharmacists' impact in chronic disease prevention and management.